Phase I Clinical Trial of TQC2731 Injection

NCT04923607 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma Severe Persistent Controlled

Interventions

DRUG: TQC2731
DRUG: Placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.